Prelude Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.2K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $43.2K | Sell |
|
|||||
|
2023
Q1 | $94.5K | Sell |
|
|||||
|
2022
Q4 | $93.5K | Sell |
|
|||||
|
2022
Q3 | $103K | Sell |
|
|||||
|
2022
Q2 | $186K | Buy |
|
|||||
|
2022
Q1 | $177K | Buy |
|
|||||
|
2021
Q4 | $172K | Buy |
|
|||||
|
2021
Q3 | $167K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $160K | Buy |
|
|||||
|
2020
Q3 | $141K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $21K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $0 | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $46K | Buy |
|